Some ads claim you can make retatrutide at home with a “government protocol” or similar recipe. No independent source confirms that any government body created or endorses such a protocol. Retatrutide is an experimental drug from Eli Lilly, and a home recipe is not the medicine and cannot be made into it. If your goal is weight loss or blood sugar control, approved treatments exist, and a clinician can help you choose among them.
| The advertised claim | A homemade retatrutide protocol |
| Government involvement | No independent source confirms any government body created, endorses or uses it |
| Can it be made at home? | No. Anything sold or described as homemade retatrutide is an imitation, not the medicine |
| What retatrutide is | An experimental once-weekly injection that targets three hormone receptors (GLP-1, GIP and glucagon); it is listed as under research, not among approved GLP-1 drugs |
| What Lilly's trial reported | Nearly 29% average weight loss over 68 weeks in people with obesity and knee osteoarthritis, with more people stopping at the top dose |
| Approved GLP-1 options today | Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide, dulaglutide and others, by prescription |
| Who should not use GLP-1 drugs | Pregnancy; personal history of medullary thyroid cancer; family history of MEN 2 |
What is the “government protocol” the ad describes?
No independent source in the medical literature describes a government-issued method for making retatrutide, and none shows any health agency endorsing one. Treat the “government” label as marketing.
If you came across a similar ad, our other pages on the same hook cover the wording differently: Government Homemade Retratutide Protocol and Free Government Home Protocol.
Can you make retatrutide at home?
No. Retatrutide is an under-research triple-receptor peptide, and approved GLP-1 medicines are available as injections or tablets. A kitchen “recipe” or ingredient mix is not that medicine and does not act on the same receptors.
Powders or vials sold as retatrutide are also a problem. Retatrutide is not an approved product, so nothing sold under that name has gone through the regulatory checks that approved GLP-1 drugs have. Wikipedia's GLP-1 overview describes gray-market sellers offering unauthorized products that they claim are GLP-1 drugs, and says buyers face risks from counterfeit or substandard drugs. It also reports an estimate from a pharmacy-regulator trade group that 95% of online compounding pharmacies were operating illegally in 2024.
What is retatrutide, and what did Lilly's trial show?
Retatrutide is an experimental once-weekly injection from Eli Lilly. It activates three receptors: GLP-1, GIP and glucagon. Wikipedia lists it among drugs under research, alongside tirzepatide (GLP-1 plus GIP). MedlinePlus, a US National Library of Medicine resource, lists the approved GLP-1 drugs, and retatrutide is not among them.
A summary of Lilly's Phase 3 results, posted by a biotech industry commentator on LinkedIn, reports:
- Nearly 29% average weight loss over 68 weeks in adults with obesity and knee osteoarthritis.
- Meaningful reductions in knee pain.
- Higher discontinuation rates at the top dose, so tolerability is something to watch.
These are the manufacturer's reported trial results, relayed secondhand. They describe people in a supervised trial, not what a home mixture would do.
How much weight can you expect to lose per week?
There is no reliable per-week figure, and weight loss on these drugs is not a steady weekly number. Trials report totals over many weeks. In randomized trials of approved GLP-1 drugs, people lost on average 5% to 20% of starting weight, depending on the drug and dose. Lilly's retatrutide trial reported nearly 29% over 68 weeks. Individual results vary widely, and doses are raised gradually to limit nausea.
Can someone with diabetes use retatrutide?
Retatrutide is still being studied, so it is not a diabetes treatment you can get as a prescription medicine. Do not substitute a homemade version for diabetes care. If you take insulin or a sulfonylurea, adding a GLP-1 drug raises the risk of low blood sugar, according to Cleveland Clinic. Any change to diabetes medication should go through your clinician.
What are the treatment options for type 2 diabetes?
Treatment usually combines lifestyle changes with medicines. Cleveland Clinic says metformin is the usual first medicine and that a GLP-1 drug may be added if metformin is not enough, is unsafe for you, or your A1C is above target. A published review in Molecular Metabolism also notes that GLP-1 drugs and insulin lower blood sugar similarly, but GLP-1 drugs usually bring weight loss rather than weight gain.
| Option | What it does | Weight effect |
|---|---|---|
| Diet and exercise | Foundation of every plan | Helps weight |
| Metformin | Usual first medicine | Roughly neutral |
| GLP-1 drugs | More insulin, less glucagon, slower stomach emptying, less appetite | Average 2 to 6 kg loss in trials |
| SGLT2 inhibitors | Heart and kidney benefits; can be combined with GLP-1 drugs | Usually some loss |
| Insulin | Replaces or adds to your own insulin | Average 1 to 2.5 kg gain |
| Sulfonylureas | Push the pancreas to release insulin | Usually gain |
Weight figures come from the Molecular Metabolism review of GLP-1 treatment. GLP-1 drugs alone do not treat diabetes; MedlinePlus says they work best with healthy eating and exercise.
How long can you stay on a GLP-1 drug?
For retatrutide there is no approved label and so no approved duration. For approved GLP-1 drugs, there is no fixed stop date in the sources here, but stopping matters. MedlinePlus says many people regain lost weight when they stop. A 2026 BMJ review cited by Wikipedia found people regained on average 50% to 70% of lost weight within a year. Researchers at the University of Chicago have modeled starting with a GLP-1 drug and then moving to cheaper maintenance such as behavioral programs, nutritionist support or lower-cost medicines. That is a model, not a trial result. Tell your clinician before you stop any medicine.
Who should not take GLP-1 drugs?
MedlinePlus says GLP-1 drugs are not recommended for:
- Pregnant women
- People with a history of medullary thyroid cancer
- People with a family history of multiple endocrine neoplasia type 2 (MEN 2)
Cleveland Clinic adds that if you can become pregnant you should use reliable birth control on these drugs. It also says the FDA has not approved them for type 1 diabetes, though some providers prescribe them off-label.
Is GLP-1 the same as Ozempic?
No. GLP-1 is a natural gut hormone, and “GLP-1 agonist” is the name of a drug class that mimics it. Ozempic is one brand of that class; its active ingredient is semaglutide.
What are the top three GLP-1 drugs?
There is no official ranking, and Cleveland Clinic says there is no single “best” way to manage diabetes or obesity. The best-known are:
| Drug | Brands | Approved for |
|---|---|---|
| Semaglutide | Ozempic, Rybelsus, Wegovy | Type 2 diabetes; Wegovy for weight management |
| Tirzepatide (GLP-1 plus GIP) | Mounjaro, Zepbound | Type 2 diabetes; Zepbound for weight management |
| Liraglutide | Victoza, Saxenda | Type 2 diabetes; Saxenda for weight management |
Wikipedia notes that semaglutide and tirzepatide ranked among the world's most popular drugs by 2024. A BMJ analysis led by University of Chicago researchers found that 15 GLP-1 drugs all lowered blood sugar and weight, with different drugs performing better in different areas.
What organ is Ozempic hard on?
No single organ is singled out, but the digestive system takes the brunt. Cleveland Clinic lists the most common side effects as loss of appetite, nausea, vomiting and diarrhea, mostly when you start or raise the dose.
| Frequency | Effects named by Cleveland Clinic and MedlinePlus |
|---|---|
| Common | Nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, headache |
| Less common | Dizziness, faster heart rate, injection-site itching or redness, reduced muscle mass, low blood sugar with insulin or sulfonylureas |
| Rare but serious | Pancreatitis, gallbladder disease, acute kidney injury, worsening diabetic retinopathy, medullary thyroid cancer risk |
Wikipedia adds that the FDA requires a boxed warning about thyroid C-cell tumors, and that a 2025 study linked the class to kidney stones and interstitial nephritis. Persistent vomiting or diarrhea, severe belly pain, or allergic symptoms such as hives or trouble breathing need urgent medical attention.
Which GLP-1 is best for kidney disease?
The sources do not name one. Wikipedia, citing the American Diabetes Association's 2025 standards, says the ADA recommends GLP-1 drugs for people with both type 2 diabetes and kidney disease. A 2023 meta-analysis it cites found SGLT2 inhibitors helped heart outcomes more when kidney function was reduced, while GLP-1 drugs worked better with higher kidney function. MedlinePlus says GLP-1 drugs improve kidney disease in some people with type 2 diabetes. Because acute kidney injury is a rare side effect, ask your kidney or diabetes specialist which drug suits your kidney function.
What actually helps?
- Talk to a clinician about approved medicines. Semaglutide (Wegovy) and tirzepatide (Zepbound) are approved for weight management. Wikipedia describes the usual criteria as a BMI of 30 or higher, or 27 or higher with a weight-related condition.
- Pair any medicine with lifestyle changes. Food, activity and behavior programs remain part of both diabetes and obesity care.
- Know your options if cost is the barrier. Cost is the biggest barrier to GLP-1 use, according to Wikipedia, but it is not a reason to turn to unregulated products.
If you are weighing telehealth services that prescribe approved GLP-1 drugs, our pages cover them separately: LeanFastRx telehealth review, JoinSkinny semaglutide page and MEDVI tirzepatide reviews. For another viral weight-loss hook, see the Bioslim “oat trick”. Other homemade-protocol claims are covered at Retratutide-Inspired Four-Ingredient Protocol.
Before you act
- If a seller says a government agency is behind a protocol, ask them to name it and link its official page. If they cannot, treat the claim as unsupported.
- Do not inject or swallow anything sold as retatrutide outside a clinical trial.
- Ask your clinician whether an approved GLP-1 drug fits your health, kidney function and other medicines.
- If you have diabetes, ask before changing any medicine, especially insulin or sulfonylureas.
- Ask what happens when you stop, since weight often returns.
By MeridianMedicalCentre.com Health Research Team